Literature DB >> 11748196

Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses.

I Méderlé1, I Bourguin, D Ensergueix, E Badell, J Moniz-Peireira, B Gicquel, N Winter.   

Abstract

Bivalent recombinant strains of Mycobacterium bovis BCG (rBCG) expressing the early regulatory nef and the structural gag(p26) genes from the simian immunodeficiency virus (SIV) SIVmac251 were engineered so that both genes were cotranscribed from a synthetic operon. The expression cassette was cloned into a multicopy-replicating vector, and the expression levels of both nef and gag in the bivalent rBCG(nef-gag) strain were found to be comparable to those of monovalent rBCG(nef) or rBCG(gag) strains. However, extrachromosomal cloning of the nef-gag operon into a replicative plasmid resulted in strains of low genetic stability that rapidly lost the plasmid in vivo. Thus, the nef-gag operon was inserted site specifically into the BCG chromosome by means of mycobacteriophage Ms6-derived vectors. The resulting integrative rBCG(nef-gag) strains showed very high genetic stability both in vitro and in vivo. The in vivo expression of the heterologous genes was much longer lived when the expression cassette was inserted into the BCG chromosome. In one of the strains obtained, integrative cloning did not reduce the expression levels of the genes even though a single copy was present. Accordingly, this strain induced cellular immune responses of the same magnitude as that of the replicative rBCG strain containing several copies of the genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748196      PMCID: PMC127622          DOI: 10.1128/IAI.70.1.303-314.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.

Authors:  A Aldovini; R A Young
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

2.  Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.

Authors:  T Zal; A Volkmann; B Stockinger
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

3.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

4.  Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series.

Authors:  J Timm; E M Lim; B Gicquel
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

5.  Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase.

Authors:  S Sturgill-Koszycki; P H Schlesinger; P Chakraborty; P L Haddix; H L Collins; A K Fok; R D Allen; S L Gluck; J Heuser; D G Russell
Journal:  Science       Date:  1994-02-04       Impact factor: 47.728

6.  Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.

Authors:  N Winter; M Lagranderie; J Rauzier; J Timm; C Leclerc; B Guy; M P Kieny; M Gheorghiu; B Gicquel
Journal:  Gene       Date:  1991-12-20       Impact factor: 3.688

7.  Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.

Authors:  N D Connell; E Medina-Acosta; W R McMaster; B R Bloom; D G Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages.

Authors:  S Xu; A Cooper; S Sturgill-Koszycki; T van Heyningen; D Chatterjee; I Orme; P Allen; D G Russell
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

9.  Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer.

Authors:  J Timm; M G Perilli; C Duez; J Trias; G Orefici; L Fattorini; G Amicosante; A Oratore; B Joris; J M Frère
Journal:  Mol Microbiol       Date:  1994-05       Impact factor: 3.501

10.  Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Authors:  C K Stover; G P Bansal; M S Hanson; J E Burlein; S R Palaszynski; J F Young; S Koenig; D B Young; A Sadziene; A G Barbour
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  30 in total

1.  Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Authors:  Mark J Cayabyab; Avi-Hai Hovav; Tsungda Hsu; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Glenn J Fennelly; Barton F Haynes; William R Jacobs; Norman L Letvin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Prions hijack tunnelling nanotubes for intercellular spread.

Authors:  Karine Gousset; Edwin Schiff; Christelle Langevin; Zrinka Marijanovic; Anna Caputo; Duncan T Browman; Nicolas Chenouard; Fabrice de Chaumont; Angelo Martino; Jost Enninga; Jean-Christophe Olivo-Marin; Daniela Männel; Chiara Zurzolo
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

3.  Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.

Authors:  Masaru Kanekiyo; Kazuhiro Matsuo; Makiko Hamatake; Takaichi Hamano; Takeaki Ohsu; Sohkichi Matsumoto; Takeshi Yamada; Shudo Yamazaki; Atsuhiko Hasegawa; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli.

Authors:  Maria de la Paz Santangelo; Petra M Gest; Marcelo E Guerin; Mathieu Coinçon; Ha Pham; Gavin Ryan; Susan E Puckett; John S Spencer; Mercedes Gonzalez-Juarrero; Racha Daher; Anne J Lenaerts; Dirk Schnappinger; Michel Therisod; Sabine Ehrt; Jurgen Sygusch; Mary Jackson
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

5.  Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.

Authors:  Asma Abdullah Nurul; Mohd Nor Norazmi
Journal:  Parasitol Res       Date:  2010-11-06       Impact factor: 2.289

6.  Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in Mycobacterium tuberculosis.

Authors:  Anna E Grzegorzewicz; Clifford Gee; Sourav Das; Jiuyu Liu; Juan Manuel Belardinelli; Victoria Jones; Michael R McNeil; Richard E Lee; Mary Jackson
Journal:  ACS Infect Dis       Date:  2019-12-11       Impact factor: 5.084

Review 7.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

8.  Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors.

Authors:  Bryan E Hart; Rose Asrican; So-Yon Lim; Jaimie D Sixsmith; Regy Lukose; Sommer J R Souther; Swati D G Rayasam; Joseph W Saelens; Ching-Ju Chen; Sarah A Seay; Linda Berney-Meyer; Leslie Magtanong; Kim Vermeul; Priyadharshini Pajanirassa; Amanda E Jimenez; Tony W Ng; David M Tobin; Steven A Porcelli; Michelle H Larsen; Joern E Schmitz; Barton F Haynes; William R Jacobs; Sunhee Lee; Richard Frothingham
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

9.  Optimisation of bioluminescent reporters for use with mycobacteria.

Authors:  Nuria Andreu; Andrea Zelmer; Taryn Fletcher; Paul T Elkington; Theresa H Ward; Jorge Ripoll; Tanya Parish; Gregory J Bancroft; Ulrich Schaible; Brian D Robertson; Siouxsie Wiles
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.